Amanote Research
Register
Sign In
Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazoloquinazolines as Selective Inhibitors of Aurora B Kinase
doi 10.1021/jm061335f.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lymphocyte-Specific Kinase: Synthesis, Structure-Activity Relationship, and in Vivo Anti-Inflammatory Activity
Discovery of a New Class of Highly Potent Inhibitors of Acid Ceramidase: Synthesis and Structure–Activity Relationship (SAR)
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Insilico Discovery of Human Aurora B Kinase Inhibitors by Molecular Docking, Pharmacophore Validation and Admet Studies
Asian Journal of Pharmaceutical and Clinical Research
Pharmacology
Pharmaceutical Science
Survivin Enhances Aurora-B Kinase Activity and Localizes Aurora-B in Human Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Discovery of a Selective Inhibitor of Oncogenic B-Raf Kinase With Potent Antimelanoma Activity
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Discovery of Inhibitors of Aurora/PLK Targets as Anticancer Agents
Kinase Inhibitors: A New Class of Antirheumatic Drugs
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Dictyostelium Aurora Kinase Has Properties of Both Aurora a and Aurora B Kinases
Eukaryotic Cell
Selective Aurora Kinase Inhibitors Identified Using a Taxol-Induced Checkpoint Sensitivity Screen
ACS Chemical Biology
Biochemistry
Medicine
Molecular Medicine
